Clinical Trial Update: A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test

View source ↗

Summary

Study exploring whether plasma free nucleic acids EGFR mutation testing can predict gefitinib efficacy in lung adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Lung Adenocarcinoma | Status: UNKNOWN